Cargando…
Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease
Parkinson's disease (PD) is a complex, multifactorial neurodegenerative disease with a prevalence of 1% over the age of 55. Neuropathological hallmarks of PD include the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of Lewy bodies that contain a variety...
Autores principales: | Kaya, Zeynep Bengisu, Karakoc, Elif, McLean, Pamela J., Saka, Esen, Atilla, Pergin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320847/ https://www.ncbi.nlm.nih.gov/pubmed/37415931 http://dx.doi.org/10.1096/fba.2022-00145 |
Ejemplares similares
-
N-Acetylcysteine Nanocarriers Protect against Oxidative Stress in a Cellular Model of Parkinson’s Disease
por: Mursaleen, Leah, et al.
Publicado: (2020) -
The efficacy of negative pressure wound therapy on chemotherapeutic extravasation ulcers: An experimental study
por: Iscı, Evren, et al.
Publicado: (2014) -
Acetylcysteine/hydroxychloroquine: Haemolysis and inflammation following off-label use of hydroxychloroquine and acetylcysteine: 7 case reports
Publicado: (2020) -
Prevention of Acoustic Trauma-Induced Hearing Loss by N-acetylcysteine Administration in Rabbits
por: Motalebi Kashani, Masoud, et al.
Publicado: (2013) -
Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysis
por: Ertan, Nesrin Zeynep, et al.
Publicado: (2017)